Proxalutamide shows promise as potential COVID-19 treatment
At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers to suspect a link between
At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers to suspect a link between
An estimated 1 in 4 older Americans with dementia or mild cognitive impairment lives alone and is at risk of practices like unsafe driving, wandering
The summertime barbecue – an American tradition synonymous with celebrating freedom – may be tainted by a decidedly unfree market.
A large-scale international collaborative study lead by Professor Jacques Simard from Université Laval and Professor Douglas Easton at the University of Cambridge, UK, has identified
Boehringer Ingelheim’s candidate stands out from other GLP-1 drugs in that it also targets the hormone glucagon. Image credit: Shutterstock/Michael Vi. Boehringer Ingelheim could soon
Credit: Meletios Verras via Shutterstock. On 16 August, Australian-based Imugene announced that it was acquiring the worldwide exclusive licence to develop and commercialise azercabtagene zarpreleucel
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s
Life science industry organisation Medilink Midlands has announced the permanent appointment of Melanie Davidson as Chief Executive Officer, and Andrea Dawson as Chief Financial and
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
It’s still cannabis earnings season, but we’re also turning to look at some of the news from the psychedelics industry. This Trade To Black Podcast,